53 related articles for article (PubMed ID: 22789707)
1. Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation.
Neukirch K; Alsabil K; Dinh CP; Bilancia R; Raasch M; Ville A; Cerqua I; Viault G; Bréard D; Pace S; Temml V; Brunner E; Jordan PM; Marques MC; Loeser K; Gollowitzer A; Permann S; Gerstmeier J; Lorkowski S; Stuppner H; Garscha U; Rodrigues T; Bernardes GJL; Schuster D; Séraphin D; Richomme P; Rossi A; Mosig AS; Roviezzo F; Werz O; Helesbeux JJ; Koeberle A
J Med Chem; 2021 Aug; 64(15):11496-11526. PubMed ID: 34279935
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the inhibitory activity of ferrocenyl Schiff bases derivatives on 5-lipoxygenase: Computational and biological studies.
Navarrete E; Morales P; Muñoz-Osses M; Vásquez-Martínez Y; Godoy F; Maldonado T; Martí AA; Flores E; Mascayano C
J Inorg Biochem; 2023 Aug; 245():112233. PubMed ID: 37141763
[TBL] [Abstract][Full Text] [Related]
3. Fucophlorethol C, a phlorotannin as a lipoxygenase inhibitor.
Kurihara H; Konno R; Takahashi K
Biosci Biotechnol Biochem; 2015; 79(12):1954-6. PubMed ID: 26155826
[TBL] [Abstract][Full Text] [Related]
4. Replacement of an Indole Scaffold Targeting Human 15-Lipoxygenase-1 Using Combinatorial Chemistry.
Prismawan D; van der Vlag R; Guo H; Dekker FJ; Hirsch AKH
Helv Chim Acta; 2019 May; 102(5):e1900040. PubMed ID: 31231138
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning Uncovers Natural Product Modulators of the 5-Lipoxygenase Pathway and Facilitates the Elucidation of Their Biological Mechanisms.
Mikutis S; Lawrinowitz S; Kretzer C; Dunsmore L; Sketeris L; Rodrigues T; Werz O; Bernardes GJL
ACS Chem Biol; 2024 Jan; 19(1):217-229. PubMed ID: 38149598
[TBL] [Abstract][Full Text] [Related]
6. Effect of solvent viscosity on the activation barrier of hydrogen tunneling in the lipoxygenase reaction.
Guevara L; Gouge M; Ohler A; Hill SG; Patel S; Offenbacher AR
Arch Biochem Biophys; 2023 Oct; 747():109740. PubMed ID: 37678425
[TBL] [Abstract][Full Text] [Related]
7. Toxicological and genotoxic evaluation of anacardic acid loaded-zein nanoparticles in mice.
Araújo JTC; Lima LA; Vale EP; Martin-Pastor M; Lima RA; Silva PGB; Sousa FFO
Toxicol Rep; 2020; 7():1207-1215. PubMed ID: 32995295
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A
Duroux R; Renault N; Cuelho JE; Agouridas L; Blum D; Lopes LV; Melnyk P; Yous S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):850-864. PubMed ID: 28661196
[TBL] [Abstract][Full Text] [Related]
9. Activity-Based Probes for 15-Lipoxygenase-1.
Eleftheriadis N; Thee SA; Zwinderman MR; Leus NG; Dekker FJ
Angew Chem Int Ed Engl; 2016 Sep; 55(40):12300-5. PubMed ID: 27612308
[TBL] [Abstract][Full Text] [Related]
10. Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties.
Eleftheriadis N; Neochoritis CG; Leus NG; van der Wouden PE; Dömling A; Dekker FJ
J Med Chem; 2015 Oct; 58(19):7850-62. PubMed ID: 26331552
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of anacardic acid on hepatitis C virus life cycle.
Hundt J; Li Z; Liu Q
PLoS One; 2015; 10(2):e0117514. PubMed ID: 25658101
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and docking studies of 2,4,6-trihydroxy-3-geranylacetophenone analogs as potential lipoxygenase inhibitor.
Ng CH; Rullah K; Aluwi MF; Abas F; Lam KW; Ismail IS; Narayanaswamy R; Jamaludin F; Shaari K
Molecules; 2014 Aug; 19(8):11645-59. PubMed ID: 25100256
[TBL] [Abstract][Full Text] [Related]
13. Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked.
Wisastra R; Dekker FJ
Cancers (Basel); 2014 Jul; 6(3):1500-21. PubMed ID: 25037020
[TBL] [Abstract][Full Text] [Related]
14. Renal cyclooxygenase products are higher and lipoxygenase products are lower in early disease in the pcy mouse model of adolescent nephronophthisis.
Yamaguchi T; Lysecki C; Reid A; Nagao S; Aukema HM
Lipids; 2014 Jan; 49(1):39-47. PubMed ID: 24178445
[TBL] [Abstract][Full Text] [Related]
15. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
Wisastra R; Ghizzoni M; Boltjes A; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2012 Aug; 20(16):5027-32. PubMed ID: 22789707
[TBL] [Abstract][Full Text] [Related]
16. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
17. Lipoxygenase inhibitory activity of anacardic acids.
Ha TJ; Kubo I
J Agric Food Chem; 2005 Jun; 53(11):4350-4. PubMed ID: 15913294
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection.
Wisastra R; Kok PA; Eleftheriadis N; Baumgartner MP; Camacho CJ; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2013 Dec; 21(24):7763-78. PubMed ID: 24231650
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
